Case Commentary: Novel Therapy for Multidrug-Resistant Acinetobacter baumannii Infection

Acinetobacter baumannii is a pathogenic bacterium commonly associated with multidrug resistance. In this issue of , a challenging case of ventilator-associated pneumonia is presented in which bacteriophage therapy was used as a last resort treatment in combination with systemic antibiotics. The data...

Full description

Saved in:
Bibliographic Details
Published in:Antimicrobial agents and chemotherapy 2022-01, Vol.66 (1), p.e0199621-e0199621
Main Authors: Eales, Brianna M, Tam, Vincent H
Format: Article
Language:English
Subjects:
Acinetobacter baumannii
Acinetobacter Infections - microbiology
Anti-Bacterial Agents - pharmacology
Anti-Bacterial Agents - therapeutic use
Antimicrobial Chemotherapy
Challenging Clinical Case in Antimicrobial Resistance
Drug Resistance, Multiple, Bacterial
Humans
Pneumonia, Ventilator-Associated - drug therapy
Pneumonia, Ventilator-Associated - microbiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acinetobacter baumannii is a pathogenic bacterium commonly associated with multidrug resistance. In this issue of , a challenging case of ventilator-associated pneumonia is presented in which bacteriophage therapy was used as a last resort treatment in combination with systemic antibiotics. The data are promising, and several key areas are highlighted for future research.
ISSN:0066-4804
1098-6596
DOI:10.1128/AAC.01996-21